Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2021-01-07 | 2021-03-04 | 131081 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131703 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131706 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2021-03-04 | 2021-03-11 | 135117 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2021-08-05 | 2021-09-09 | 143719 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157271 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183389 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183410 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190695 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-08 | 2023-07-21 | 194109 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195216 |
TEVA-OLANZAPINE | 10MG | TABLET | Actual shortage | 2025-02-13 | 2025-04-04 | 250390 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2025-04-10 | 2025-05-08 | 254789 |
TEVA-OLANZAPINE | 7.5MG | TABLET | Actual shortage | 2025-05-02 | 2025-05-08 | 256453 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-04-28 | 2022-12-22 | 159593 |
TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-05-19 | 2022-08-19 | 161000 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161952 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2022-06-03 | 2022-08-09 | 161955 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-09 | 163930 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |